Fig 1.
Flowchart of drugs authorized for use under Emergency Use Authorization by FDA against COVID-19.
COVID-19: Coronavirus disease 2019, EUA: Emergency Use Authorization.
Table 1.
Status of approval/use authorization in each country for drugs granted the Emergency Use Authorization by FDA.
Table 2.
Development status in each country for drugs granted the Emergency Use Authorization by FDA.
Fig 2.
Review period of regulatory authority in each country for drugs authorized for use under Emergency Use Authorization by FDA against COVID-19.
The horizontal line in each box represents the median. The x mark represents the average values. The lines at the top and bottom edges of each box represent the 75th and 25th percentiles, respectively. The upper and lower limits of the vertical lines represent the maximum and minimum values, respectively. US: United States; JP: Japan; EU: Europe; UK: United Kingdom.
Fig 3.
Period from the date of grant for Emergency Use Authorization to the date of approval in each country.
The horizontal line in each box represents the median. The x mark represents the average values. The lines at the top and bottom edges of each box represent the 75th and 25th percentiles, respectively. The upper and lower limits of the vertical lines represent the maximum and minimum values, respectively. JP: Japan, EU: Europe, UK: the United Kingdom.
Table 3.
Summary of emergency approval/use authorization regulations in each country.